Nov 30, 2021 / 10:10PM GMT
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Outstanding. Listen, guys, pleasure to have Amgen management join us to -- and a great first day at our conference. We have -- we were scheduled to have Arvind and Rob from the global development side, and I just learned that Peter is joining us as well. So thank you to all of you for being here.
Maybe I'll turn it over to you, Peter, just to kick things off, and we'll jump right into it.
Peter H. Griffith - Amgen Inc. - Executive VP & CFO
How are you doing, Umer? It's great to be here. It's nice to hear you and Eric and Mike. We appreciate the invitation as always. So thank you. And I'd just like to maybe share a few remarks on behalf of all of us at Amgen.
We feel like the company is well positioned for attractive long-term growth. Our 3 main drivers are volume-driven growth of our innovative brands and our biosimilar portfolio. We feel great about that. Secondly, some successful near-term launches: LUMAKRAS, as we all
Amgen Inc at Evercore ISI HealthCONx Virtual Conference Transcript
Dec 01, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers